SYTL4

SYTL4 (Slp4-a/granuphilin) is a Rab27A effector that controls the docking and Ca²⁺-triggered fusion of dense-core secretory granules and Weibel-Palade bodies (WPBs) by bridging vesicular Rab GTPases to the plasma-membrane SNARE-priming machinery (PMID:12176990, PMID:16481396). Through its N-terminal Slp homology domain it engages Rab27A in both nucleotide states, using distinct sub-domains (the SHD2 TGDWFY motif for GDP-bound Rab27A and SHD1 for the GTP-bound form), with the GDP-bound interaction being the dominant route by which it inhibits exocytosis (PMID:12590134). Its central linker domain directly binds the Munc18-1·syntaxin-1a complex—and Munc18-2·syntaxin-2/3 in exocrine acinar cells—to dock granules at the plasma membrane while ultimately suppressing KCl-evoked secretion, since increasing docked-vesicle number is uncoupled from fusion and the linker is required for the inhibitory effect (PMID:16186111, PMID:16481396). In endothelial cells SYTL4 instead acts as a positive regulator of hormone-evoked WPB exocytosis and von Willebrand factor release, recruiting STXBP1 together with syntaxin-2/3, an activity opposed by MyRIP at the same Rab27A docking site (PMID:22898601, PMID:24700782). Independent of its secretory role, SYTL4 directly binds microtubules through its linker–C2A region and inhibits microtubule polymerization, a function that promotes paclitaxel resistance in triple-negative breast cancer (PMID:33042263).

1. 2002 High

   Established Slp4-a as a Rab27A-specific effector on dense-core vesicles and a negative regulator of exocytosis, defining its first molecular partner and functional output.

   Evidence Co-IP, subcellular fractionation, and NPY secretion assay with a Rab27A-binding-deficient mutant in PC12 cells

   PMID:12176990

   Open questions at the time

   • Did not resolve which downstream plasma-membrane machinery executes the inhibition
   • Rab8 interaction left functionally uncharacterized
2. 2003 High

   Defined the dual nucleotide-state recognition of Rab27A by distinct SHD sub-domains and identified GDP-bound binding as the mechanism of secretion inhibition, while linking Slp4-a to Munc18-1.

   Evidence Domain deletion/point mutagenesis, immunoprecipitation, and NPY secretion assays in PC12 cells

   PMID:12590134

   Open questions at the time

   • Structural basis of simultaneous GDP/GTP-form binding not resolved
   • Functional consequence of Munc18-1 binding not yet established at this stage
3. 2005 High

   Extended the mechanism to exocrine cells by showing the linker domain engages syntaxin-2/3 via Munc18-2 and is required for stimulated secretion, establishing tissue-specific SNARE partner usage.

   Evidence Co-IP, deletion mapping, endogenous complex detection, and antibody-inhibition amylase release in permeabilized parotid acinar cells

   PMID:16186111

   Open questions at the time

   • Whether syntaxin-2/3 engagement is activating or inhibitory in this context not fully disentangled
   • Direct versus Munc18-bridged contact not separated
4. 2006 High

   Resolved the bridging model—linker-domain Munc18-1 binding drives vesicle docking yet exocytosis is still inhibited—demonstrating that docking and fusion are mechanistically uncoupled by Slp4-a.

   Evidence Chimeric Slp4-a/Slp5 domain swaps, co-IP, morphological docking assay, and NPY secretion in PC12 cells

   PMID:16481396

   Open questions at the time

   • Molecular step at which fusion is blocked downstream of docking not defined
   • Whether the GDP-Rab27A interaction and Munc18-1 bridging act independently unclear
5. 2006 High

   Placed granuphilin/Slp4 expression under transcriptional and microRNA control, showing the mir-9→Onecut-2→granuphilin axis tunes insulin-secreting cell exocytosis.

   Evidence EMSA, ChIP, RNAi, and secretion assays in insulin-secreting cells

   PMID:16831872

   Open questions at the time

   • Did not test SYTL4 protein-level mechanism, only its regulation
   • Direct effect of granuphilin dose on fusion not measured here
6. 2009 Medium

   Distinguished Slp4-a from MyRIP by showing it is stably retained on apical membrane and granules without stimulus-evoked redistribution or degradation, indicating a constitutive scaffolding role.

   Evidence Subcellular fractionation and immunoblotting after isoproterenol stimulation in rat parotid acinar cells

   PMID:19185850

   Open questions at the time

   • Single-lab fractionation without live imaging
   • Functional meaning of stable localization not directly tested
7. 2012 High

   Revealed a context-dependent reversal of polarity—in endothelial WPBs Slp4-a is a positive regulator of exocytosis, with release probability set by competition with MyRIP for Rab27A.

   Evidence siRNA knockdown, EGFP-Slp4-a overexpression, VWF secretion, and localization in endothelial cells

   PMID:22898601

   Open questions at the time

   • Molecular basis for opposite directionality versus PC12 cells not defined
   • Stoichiometry of Slp4-a vs MyRIP occupancy not quantified in vivo
8. 2014 High

   Identified STXBP1 and syntaxin-2/3 as endogenous SYTL4 partners by unbiased proteomics and linked the Rab27A–Slp4-a–STXBP1 complex to VWF secretion, including a human STXBP1-haploinsufficient phenotype.

   Evidence Proteomic screen, co-IP, siRNA, and patient-derived blood outgrowth endothelial cells with VWF secretion readout

   PMID:24700782

   Open questions at the time

   • Whether STXBP1 recruitment is direct or via syntaxin not resolved
   • Mechanism converting docking into productive fusion still incomplete
9. 2020 Medium

   Uncovered a secretion-independent function: SYTL4 directly binds and destabilizes microtubules via its linker–C2A region, linking it to paclitaxel resistance in TNBC.

   Evidence Colocalization, microtubule pulldown, in vitro polymerization assay, siRNA with dynamics readout, mouse and organoid models

   PMID:33042263

   Open questions at the time

   • Single-lab, unreplicated finding
   • Relationship between microtubule and secretory functions not integrated
   • No structural detail of the microtubule-binding interface
10. 2025 Low

    Implicated SYTL4-mediated exocytosis in CXCL8 secretion in pancreatic cancer downstream of glutamine metabolism and mTOR/NF-κB signaling.

    Evidence Knockdown, CXCL8 secretion assay, and in vivo tumor models in pancreatic cancer cells

    PMID:41444422

    Open questions at the time

    • Limited mechanistic detail on how SYTL4 specifically mediates CXCL8 exocytosis
    • Single lab, not independently confirmed
    • Rab27A/SNARE dependence in this context not tested

• How SYTL4 switches between negative regulation (dense-core granules) and positive regulation (WPBs), and how its microtubule-destabilizing activity relates to its secretory scaffolding role, remain unresolved.
• No structure of the Rab27A–Slp4-a–Munc18/syntaxin assembly
• Determinants of cell-type-specific directionality unknown
• Whether microtubule and exocytic functions are mutually exclusive untested